Clinical Trial

Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer

Name: Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer — clinical trial record (NCT07179744)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine whether certain patients can safely omit regional lymph node radiotherapy. These women must have hormone-sensitive, Her2-negative tumors, have 1-3 positive axillary nodes and have RecurIndex low-risk.

Trial Details

NCT Number	NCT07179744
Lead Sponsor	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Collaborators: Sun Yat-sen University
Conditions	Breast Cancer
Enrollment	635 participants
Start Date	2022-07-06
Primary Completion	2027-07-06 (estimated)
Study Completion	2032-07-05 (estimated)
Updated on ClinicalTrials.gov	2025-09-18